FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19215711000001107: Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-Jun 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
65110801000001114 Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
65110901000001115 Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) Is a Product containing precisely risedronate sodium 35 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) Has active ingredient Risedronate sodium false Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) Has specific active ingredient Risedronate sodium true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) 4 tablet Has AMP True Risedronate sodium 35mg tablets (Bluefish Pharmaceuticals AB) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start